Over the past 3 months, 8 analysts have published their opinion on Edwards Lifesciences (NYSE:EW) stock. These analysts…
January 6, 10:22 AM
Morgan Stanley analyst Cecilia Furlong maintains Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $92 to $95.
Jim Cramer Recommends These 5 Healthcare Stocks For 2023: ‘Biggest Winners Were Boring, Consistent Operators’
December 16, 7:34 AM
Prominent market commentator Jim Cramer has recommended five healthcare stocks which he believes should be on investors’ shopping list for 2023.
December 13, 5:34 AM
Raymond James analyst Jayson Bedford maintains Edwards Lifesciences (NYSE:EW) with a Outperform and lowers the price target from $85 to $83.
December 6, 8:46 AM
Morgan Stanley raised JPMorgan Chase & Co. (NYSE:JPM) price target from $126 to $153. . Morgan Stanley analyst…
November 28, 10:14 AM
Goldman Sachs boosted the price target on Reata Pharmaceuticals, Inc. (NASDAQ: RETA) from $86 to $115. Goldman Sachs analyst Madhu Kumar maintained the stock with a Buy rating. Reata Pharmaceuticals shares rose 1.9% to close at $36.03 on Friday.
November 28, 8:44 AM
RBC Capital analyst Shagun Singh maintains Edwards Lifesciences (NYSE:EW) with a Outperform and lowers the price target from $118 to $105.